Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-000110

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 226,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Ward Robert CHIEF EXECUTIVE OFFICER 2019-01-30 Grant or award · Stock Options +226,000 226,000 D
Loading xslF345X03/form4-01312019_040118.xml…